Open access · US-GOV
via ClinicalTrials.gov Clinical trial
CENP-V as a Potential Diagnostic Marker of Damage in Human Oocytes
Authors not listed
Vida Recoletas Sevilla · 2024
Abstract
Proper chromosome segregation is essential to avoid aneuploidy, yet in mammalian oocytes it progressively fails in an age-dependent manner. The ageing population and the increasing age of parenthood are leading to a declined fertility. Proteins contributing to correct chromosome segregation and oocyte ageing are therefore of central interest. Mouse oocytes deficient in CENP-V are strongly impaired in meiosis I. The spindle assembly checkpoint (SAC)-dependent arrest of about half of the Cenp-V -/- oocytes at metaphase I is only found in oocytes from young adults, not in oocytes \>12 months. This suggests SAC weakening in ageing oocytes allowing them to proceed despite continuous presence of mis-aligned chromosomes and present CENP-V depleted oocytes as a model for age dependent weakening of the SAC. Sporadic cases of very-low oocyte survival rate have been observed after vitrification and thawing protocols in the clinical practice. However, no diagnostic tools are currently available to detect these cases. The relevance of this problem has led to a demand on the scientific community to obtain specific and early biomarkers to predict decreased oocyte survival rates after thawing. The main goal of this project is to establish the expression levels of the CENP-V protein in human oocytes as a diagnostic tool for the aging of a cohort of oocytes. With this purpose, the immature oocytes from the oocytes cohort recovered from women with advanced maternal age (AMA) and control, will be matured in vitro in order to compare the CENP-V expression levels between both populations. In addition, in patients with AMA, these expression levels will be correlated with the aneuploidy rate from the blastocyst of the same oocyte cohort. CENP-V-deleted mouse oocytes show higher rate of aneuploidy and spindle aberrations after cold treatment compared to control oocytes. We hypothesize that alterations in the expression level of CENP-V could be responsible of the decrease in oocyte survival rate after thawing. The main objective of this project is to establish the expression levels of the CENP-V protein in human oocytes as a diagnostic tool to assess the damage of a cohort of oocytes. For this purpose, oocytes retrieved from advanced maternal age (AMA) and control patients, as well as oocytes undergoing vitrification / thawing procedures and controls oocytes, will be analyzed. In this study, only the immature oocytes of the patients, which are destined to be discarded and not used in their treatment, will be analyzed.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- ClinicalTrials.gov
- Canonical
- link ↗
- Fetched
- 2026-10-21 MST
Cite this
APA
Anonymous. (2024). CENP-V as a Potential Diagnostic Marker of Damage in Human Oocytes. <em>Vida Recoletas Sevilla</em>. https://clinicaltrials.gov/study/NCT06788379
Vancouver
Anonymous. CENP-V as a Potential Diagnostic Marker of Damage in Human Oocytes. Vida Recoletas Sevilla. 2024.
BibTeX
@misc{anon2024CENPVa,
title = {CENP-V as a Potential Diagnostic Marker of Damage in Human Oocytes},
author = {Anonymous},
journal = {Vida Recoletas Sevilla},
year = {2024},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Aging Cell 2019
Open access · CC-BY
NMNAT2‐mediated NAD+ generation is essential for quality control of aged oocytes
Ottawa Hospital Research Institute 2002
Open access · US-GOV
Creation, Evaluation and Validation of a Preoperative Frailty Index Using Health Administrative Data: a Population-based Cohort Study
Peking Union Medical College Hospital 2015
Open access · US-GOV
Is Regional Citrate Anticoagulation With Fixed Citrate Blood Concentration More Effective and Easy-to-handle Than Adjusted-dose Protocol in Adult Critically Ill Patients? A Cohort Study
Cellular and Molecular Life Sciences 2025
Open access · CC-BY
Nano-encapsulated senolytic cocktail attenuates germ cell senescence in female mice
Unidade Local de Saúde de Coimbra, EPE 2024
Open access · US-GOV
Effects of Resveratrol Supplementation on Oocyte Quality in Advanced Maternal Aged Women Undergoing in Vitro Fertilization.
Molecular Human Reproduction 2024
Preprint · OA